Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
about
sameAs
The European Organization for Research and Treatment of Cancer perspective on designing clinical trials with immune therapeuticsHER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practiceConfronting the Care Delivery Challenges Arising from Precision MedicineMechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome ItTargeted therapies with companion diagnostics in the management of breast cancer: current perspectivesMolecular Imaging of Biomarkers in Breast CancerDevelopment of Companion DiagnosticsThe fate of chemoresistance in triple negative breast cancer (TNBC)Biological markers of invasive breast cancerNatHER: protocol for systematic evaluation of trends in survival among patients with HER2-positive advanced breast cancerPersonalized Medicine: Genomics Trials in OncologyProgress in adjuvant chemotherapy for breast cancer: an overviewMolecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case PresentationNot All Next Generation Sequencing Diagnostics are Created Equal: Understanding the Nuances of Solid Tumor Assay Design for Somatic Mutation DetectionBiomarker validation and testingProfile of neratinib and its potential in the treatment of breast cancerHER2 as a therapeutic target in head and neck squamous cell carcinomaMicrofluidic platform combining droplets and magnetic tweezers: application to HER2 expression in cancer diagnosis.Novel method for rapid in-situ hybridization of HER2 using non-contact alternating-current electric-field mixing.Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast CancerValidation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validationTrastuzumab in the management of gastroesophageal cancer: patient selection and perspectivesHER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologistsUse of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineRecent advances in the development of anti-HER2 antibodies and antibody-drug conjugatesLong term side effects of adjuvant chemotherapy in patients with early breast cancerEpidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancerFrom bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid ClassesProspective Validation of a 21-Gene Expression Assay in Breast Cancer14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts.Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015).Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivationInvasive cribriform carcinoma of the breast: A report of nine cases and a review of the literatureImpact of updated HER2 testing guidelines in breast cancer--re-evaluation of HERA trial fluorescence in situ hybridization data.Real-world data in the molecular era-finding the reality in the real world.Ioncopy: a novel method for calling copy number alterations in amplicon sequencing data including significance assessment.Pertuzumab and breast cancer: another piece in the anti-HER2 puzzle.Retrospective study of the efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab (TCH-P) in nonmetastatic HER2-positive breast cancer.NDER: A novel web application using annotated whole slide images for rapid improvements in human pattern recognition
P2860
Q26738677-5CA063A7-3BEF-4A9D-870E-378764C9F23EQ26741253-653A1278-7F5B-4DD2-A8F6-358759C71850Q26747282-2D154031-1BA5-4B0C-AD29-D599F6D3ADBBQ26752780-07364FFD-8D8A-42A1-A5F5-DBE08B4C1129Q26768119-8031FA95-942D-49A1-B999-4BD690AE2E60Q26772870-556104BB-2C2D-4FEA-B691-083F46CBDC61Q26774670-F334B59C-EC2B-4F7F-BFA2-B2A8584F6067Q26775232-DC182387-005C-4E32-8347-5E31585D110BQ26781177-DBB19E60-EA8C-4A58-89F1-74139BADEA9DQ26782856-9E34B148-B166-4FD6-9FA0-B9F924E25B23Q26795376-F6E1F668-11BD-4053-AD95-5F5165513C85Q26798078-77979B2D-EBB8-46D3-8714-39C5ECE0A8D2Q26800626-2534D3AE-6E90-41F3-BE6D-BF020D4672E8Q26801745-4B7D9DFF-A865-4D83-9E18-8E6ED3B9FE9EQ26863672-B21B01E3-CF75-4E66-BBFC-03C089FDE8C4Q27012540-47ED7B64-880D-48A1-9668-ABE776A7EC11Q27026178-F4936C95-15FE-469E-9831-3E1C7A7188D4Q27316870-D2D26B01-FCE0-4D5D-B04E-FB8525E5DDB2Q27324543-C64478D8-BE4B-484A-8F45-E1F941614F5AQ28072513-B7B6F83F-6BC4-4298-8F77-3F5A3B19B09CQ28075719-A25EA732-CFD8-4301-A916-AA26AACBE988Q28077666-F1BCACEF-E969-4E5D-8660-E268F2C4D67BQ28078111-F116A934-5A49-49EB-A129-DD4D77FE52E0Q28079118-93DAFB72-25F7-4C2C-B8C2-3BA17D805ECCQ28083123-B8C9048C-86C7-4515-8FDE-65CC17391969Q28083233-CED50625-F4DD-4990-9AB2-7EBD02644562Q28084216-9FD6616E-6EB9-4E32-A2AD-E781CB4C2D4AQ28084982-23979DC8-B72C-4F07-B486-5D5530973752Q28554412-C532CAA6-8C6E-4001-91E3-F08517B835E0Q29011698-E9D8B2DE-BA32-46BE-971F-556F79B918D7Q30315970-39AFF9F1-7E0B-4E9B-96D0-5F0F1DC606B1Q30316383-39A38F9B-8DE7-473C-8368-9A39C73E1938Q30369607-F86FD6E3-DA44-4E8C-8FDD-C4403A0AE745Q30416537-7E75735B-C7C8-439C-BB09-D16DEEB86EA9Q30996906-3C3D7B39-B964-44F8-A67D-5B7D6B49CC5BQ31023009-474E7A70-07E4-4938-A8C7-B5E96B64ECC1Q31048851-53856952-16D2-490E-BDEF-C395E012BE05Q33364587-FE851EC2-D54E-49BF-B7A6-0428A4B6744AQ33433275-E6389E45-204D-4262-B37C-8DA04AB56AC9Q33450398-64EAD0FC-AA52-4CD8-BC77-2239DAD5E58B
P2860
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
description
article
@en
im November 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2013
@uk
name
Recommendations for human epid ...... ical practice guideline update
@en
Recommendations for human epid ...... ical practice guideline update
@nl
type
label
Recommendations for human epid ...... ical practice guideline update
@en
Recommendations for human epid ...... ical practice guideline update
@nl
altLabel
Recommendations for Human Epid ...... ical Practice Guideline Update
@en
Recommendations for Human Epid ...... ical Practice Guideline Update
@nl
prefLabel
Recommendations for human epid ...... ical practice guideline update
@en
Recommendations for human epid ...... ical practice guideline update
@nl
P2093
P50
P356
P1476
Recommendations for Human Epid ...... ical Practice Guideline Update
@en
Recommendations for human epid ...... ical practice guideline update
@en
P2093
Antonio C Wolff
Antonio C. Wolff
Daniel F Hayes
Daniel F. Hayes
David G Hicks
David G. Hicks
Donald C Allred
Donald C. Allred
Edith A Perez
Edith A. Perez
P304
P356
10.1200/JCO.2013.50.9984
P407
P577
2013-11-01T00:00:00Z